Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Fumihiko Monma"'
Autor:
Kei Suzuki, Koji Oka, Takao Sekine, Masahiro Okuda, Naoyuki Katayama, Akira Umino, Keiki Kawakami, Fumihiko Monma, Takuya Iwamoto, Kohshi Ohishi
Publikováno v:
Therapeutic Drug Monitoring. 41:575-581
Tyrosine kinase inhibitors markedly improve the survival for patients with chronic myeloid leukemia (CML). However, a decrease in adherence leads to undesired therapeutic outcomes. In this study, the relationships among adherence, pharmacokinetics, r
Autor:
Akiko Nakamura, Atsushi Fujieda, Masahiro Masuya, Kazunori Nakase, Fumihiko Monma, Naoyuki Katayama, Kohshi Ohishi, Yuka Sugimoto
Publikováno v:
Advances in Microbiology. :971-982
Blood stream infections (BSIs) are a serious problem in patients with hematologic malignancies receiving allogeneic hematopoietic stem cell transplantation (ASCT). We evaluated the clinical utility of molecular diagnosis for the management of BSIs in
Autor:
Kohshi Ohishi, Naoyuki Katayama, Akiko Nakamura, Kana Miyazaki, Atsushi Fujieda, Yoshiki Nakamori, Kazuko Ino, Yuka Sugimoto, Kazunori Nakase, Fumihiko Monma, Masahiro Masuya, Yumiko Sugawara
Publikováno v:
Internal Medicine
Pulmonary mucormycosis (PM) is a life-threatening fungal infection in patients with hematologic malignancies, and early and accurate diagnostic modalities are urgently needed. We conducted a polymerase chain reaction (PCR) assay targeting these fungi
Autor:
Shimon Sakaguchi, Hiroyoshi Nishikawa, Yuka Maeda, Yoshiko Takeuchi, Toshio Kitawaki, Elke Jäger, Fumihiko Monma, Danbee Ha, Yoshihiro Kameoka, Atsushi Tanaka, Naoto Takahashi, Naoyuki Katayama, Kohshi Ohishi, Shinsuke Noguchi, Yoshinori Shinohara, Kenichi Sawada, Keiko Iwaisako, Julia Karbach, Hiromasa Morikawa, Takuro Saito, Daisuke Sugiyama, Naoya Shigeta
Publikováno v:
The Journal of Experimental Medicine
As a novel type of anticancer reagent, imatinib inhibits not only BCR-ABL oncogenic protein but also LCK in T cells as an off-target, being able to selectively deplete mature T reg cells and thereby evoke effective immune responses to various cancers
Autor:
Tsutomu Nobori, Masahiro Masuya, Toshimitsu Matsui, Akiko Sada, Fumihiko Monma, Naoyuki Katayama, Yuji Shimokariya, Yuka Sugimoto, Kohshi Ohishi
Publikováno v:
Cancer Genetics. 208:508-512
We identified a novel fusion gene, FOXP1-PDGFRA, in a patient with myeloproliferative neoplasm (MPN) with eosinophilia, harboring the chromosome abnormality t(3;4)(p13;q12). The patient responded well to imatinib and has remained in molecular remissi
Autor:
Fumihiko Monma, Masahiro Okuda, Alberto Alexander Gayle, Takuya Iwamoto, Atsushi Fujieda, Kaname Nakatani, Tsutomu Nobori, Naoyuki Katayama
Publikováno v:
Therapeutic Drug Monitoring. 37:581-588
BACKGROUND Blood tacrolimus (TAC) concentration delivered via intravenous administration is known to be influenced by genetic polymorphism of CYP3A5 and interaction with triazole antifungal agents. However, interindividual variability of blood TAC co
Autor:
Motohiko, Okano, Yuka, Sugimoto, Koshi, Ohishi, Kana, Miyazaki, Fumihiko, Monma, Naoyuki, Katayama
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 58(7)
Chronic myeloid leukemia (CML) typically causes leukocytosis rather than thrombocytosis. We encountered two women in their thirties with remarkable thrombocytosis, whose platelet counts were over 3,000×10
Autor:
Kohshi Ohishi, Hideo Wada, Kazunori Nakase, Yuka Sugimoto, Akiko Nakamura, Kei Suzuki, Naoyuki Katayama, Fumihiko Monma, Tsutomu Nobori, Masahiro Masuya, Yoshiko Matsushima, Yumiko Sugawara, Atushi Fujieda
Publikováno v:
European Journal of Haematology. 90:331-339
Objectives Invasive fungal diseases (IFDs) are life-threatening events in patients with haematologic disorders, and the spectrum of the aetiological pathogens continues to expand. This study aimed to evaluate the clinical utility of a panfungal polym
Autor:
Kaoru Dohi, Naoki Fujimoto, Masaaki Ito, Tetsushiro Takeuchi, Fumihiko Monma, Naoyuki Katayama, Kazuko Ino
Publikováno v:
International journal of cardiology. 212
Autor:
Takahiro Yamauchi, Motohiro Tsuzuki, Masatomo Takahashi, Norio Asou, Hitoshi Kiyoi, Kentaro Horikawa, Takaaki Ono, Yuji Kishimoto, Masako Iwanaga, Fumihiko Monma, Akihiro Takeshita, Masaya Okada, Tomoki Naoe, Shigeki Ohtake, Yukihiko Kimura, Chiaki Nakaseko, Katsuji Shinagawa, Mitsuhiro Matsuda
Publikováno v:
Cancer Science. 103:1974-1978
Studies focused on elderly acute promyelocytic leukemia (APL) are relatively limited. To evaluate prognostic impact in elderly APL, we compared the long-term outcome of elderly APL patients (60-70 years) with younger patients (15-59 years) treated wi